Latest Market Data
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

GRAND PHARMACEUTICAL GROUP LTD. (512)

GRAND PHARMA (512)

HK$9.400

0.000 (0.00%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$9.400
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$9.500
TURNOVER
HK$194.65M
VOLUME
20.50M
MKT CAP
HK$33.36B
LOT SIZE
500
BID
HK$9.390
ASK
HK$9.400
EPS
HK$0.7049
P/E
13.34x
DIV YIELD
2.77%
INTRA-DAY 52W
High HK$9.800 HK$10.200
Low HK$9.310 HK$4.040
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 23 Jul 2025 16:08 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.00.0008.8809.1209.3609.6009.8400400K800K10:0011:0012:0013:0014:0015:0016:00Prev. Close
9.400
All charts use the last traded price or closing price.

COMPANY PROFILE

Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 3,549,571,148 (as at 30 Jun 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Pharmaceuticals Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Listing Date 19 Dec 1995
Financial Year Ends 31 Dec 2024
Chairman Tang Weikun
Principal Office Unit 3302
The Centre
99 Queen's Road Central
Hong Kong
Place of Incorporation Bermuda
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 23 Jul 2025 18:39 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
12 Mar 202514 Apr 2025Fin Div HKD 0.2631 Dec 202416 Apr 2025 - 16 Apr 202528 Apr 2025
19 Aug 2024-No Dividend for the period ended
2024/06/30
31 Dec 2024--
19 Mar 202406 Jun 2024Fin Div HKD 0.2631 Dec 202311 Jun 2024 - 11 Jun 202427 Jun 2024
10 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
22 Mar 202309 Jun 2023Fin Div HKD 0.1431 Dec 202213 Jun 2023 - 13 Jun 202327 Jun 2023
LOAD MORE
Updated: 23 Jul 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews